These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 10448113)

  • 1. Multi-step evolution of lung cancer.
    Braithwaite KL; Rabbitts PH
    Semin Cancer Biol; 1999 Aug; 9(4):255-65. PubMed ID: 10448113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronology of genetic lesions in lung neoplasia.
    Sozzi G; Pilotti S; Pezzella F; Pastorino U; Pierotti MA
    Ann Pathol; 1997; 17 Suppl 5():25-6. PubMed ID: 9421608
    [No Abstract]   [Full Text] [Related]  

  • 3. High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints.
    Wistuba II; Behrens C; Virmani AK; Mele G; Milchgrub S; Girard L; Fondon JW; Garner HR; McKay B; Latif F; Lerman MI; Lam S; Gazdar AF; Minna JD
    Cancer Res; 2000 Apr; 60(7):1949-60. PubMed ID: 10766185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preinvasive lesions of the bronchus.
    Rivera MP
    Clin Chest Med; 2011 Dec; 32(4):693-702. PubMed ID: 22054880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The expression of fatty acid synthase (FASE) is an early event in the development and progression of squamous cell carcinoma of the lung.
    Piyathilake CJ; Frost AR; Manne U; Bell WC; Weiss H; Heimburger DC; Grizzle WE
    Hum Pathol; 2000 Sep; 31(9):1068-73. PubMed ID: 11014573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [From dysplasia to cancer: cytologic, histopathologic and molecular aspects].
    Vignaud JM
    Rev Mal Respir; 1999 Jan; 16 Suppl 3():S107-11. PubMed ID: 10088273
    [No Abstract]   [Full Text] [Related]  

  • 7. Altered global methylation of DNA: an epigenetic difference in susceptibility for lung cancer is associated with its progression.
    Piyathilake CJ; Frost AR; Bell WC; Oelschlager D; Weiss H; Johanning GL; Niveleau A; Heimburger DC; Grizzle WE
    Hum Pathol; 2001 Aug; 32(8):856-62. PubMed ID: 11521231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Abnormalities of molecular biology in premalignant lung lesions].
    Shao SJ; Wang Y; Yang PM
    Ai Zheng; 2004 Jan; 23(1):99-103. PubMed ID: 14720385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SCCRO expression correlates with invasive progression in bronchioloalveolar carcinoma.
    Sarkaria IS; Pham D; Ghossein RA; Talbot SG; Hezel M; Dudas ME; Ebright MI; Chuai S; Memoli N; Venkatraman ES; Miller VA; Kris MG; Zakowski MF; Rusch VW; Singh B
    Ann Thorac Surg; 2004 Nov; 78(5):1734-41. PubMed ID: 15511464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic progression and heterogeneity associated with the development of esophageal squamous cell carcinoma.
    Roth MJ; Hu N; Emmert-Buck MR; Wang QH; Dawsey SM; Li G; Guo WJ; Zhang YZ; Taylor PR
    Cancer Res; 2001 May; 61(10):4098-104. PubMed ID: 11358832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromosome 5p aberrations are early events in lung cancer: implication of glial cell line-derived neurotrophic factor in disease progression.
    Garnis C; Davies JJ; Buys TP; Tsao MS; MacAulay C; Lam S; Lam WL
    Oncogene; 2005 Jul; 24(30):4806-12. PubMed ID: 15870700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gain of 1q25-32, 12q23-24.3, and 17q12-22 facilitates tumorigenesis and progression of human squamous cell lung cancer.
    Ma J; Gao M; Lu Y; Feng X; Zhang J; Lin D; Xiao T; Hu Z; Yuan J; Su K; Shipley J; Xue J; Gao Y
    J Pathol; 2006 Oct; 210(2):205-13. PubMed ID: 16927450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of vascular endothelial growth factor and its receptors in bronchial dypslasia demonstrated by quantitative RT-PCR analysis.
    Merrick DT; Haney J; Petrunich S; Sugita M; Miller YE; Keith RL; Kennedy TC; Franklin WA
    Lung Cancer; 2005 Apr; 48(1):31-45. PubMed ID: 15777969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Precursors to pancreatic cancer].
    Søreide K; Immervoll H; Molven A
    Tidsskr Nor Laegeforen; 2006 Mar; 126(7):905-8. PubMed ID: 16554881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promoter hypermethylation of hallmark cancer genes in atypical adenomatous hyperplasia of the lung.
    Licchesi JD; Westra WH; Hooker CM; Herman JG
    Clin Cancer Res; 2008 May; 14(9):2570-8. PubMed ID: 18451218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular pathology of lung cancer.
    Wistuba II; Gazdar AF
    Verh Dtsch Ges Pathol; 2000; 84():96-105. PubMed ID: 11217455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
    Zhang H; Stephens LC; Kumar R
    Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular profiling of lung carcinoma: identifying clinically useful tumor markers for diagnosis and prognosis.
    Dacic S
    Expert Rev Mol Diagn; 2007 Jan; 7(1):77-86. PubMed ID: 17187486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of c-ErbB1/epidermal growth factor receptor and c-ErbB2/HER-2 expression in bronchial dysplasia: evaluation of potential targets for chemoprevention of lung cancer.
    Merrick DT; Kittelson J; Winterhalder R; Kotantoulas G; Ingeberg S; Keith RL; Kennedy TC; Miller YE; Franklin WA; Hirsch FR
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2281-8. PubMed ID: 16609045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Precancer and cancer of the lung].
    Kogan EA
    Arkh Patol; 1989; 51(11):76-83. PubMed ID: 2695019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.